|16.01||-0.52 / -3.15%|
As of 4:00pm ET
|16.01||-0.003 / -0.02%|
The 6 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 26.00, with a high estimate of 38.00 and a low estimate of 23.00. The median estimate represents a +62.40% increase from the last price of 16.01.
The current consensus among 7 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.